Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Shenouda Maged Create: Alert

All | News | Filings
Date FiledTypeDescription
05/30/2023 4 Shenouda Maged (CFO) has filed a Form 4 on RELMADA THERAPEUTICS, INC.
Txns: Granted 317,643 options to buy @ $3.37, valued at $1.1M
12/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/26/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/21/2021 4 Shenouda Maged (CFO) has filed a Form 4 on RELMADA THERAPEUTICS, INC.
Txns: Granted 227,518 options to buy @ $19.03, valued at $4.3M
03/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/29/2021 4 Shenouda Maged (CFO) has filed a Form 4 on RELMADA THERAPEUTICS, INC.
Txns: Sold 1,800 shares @ $31.59, valued at $56.9k
Sold 1,200 shares @ $32.43, valued at $38.9k
Exercised 3,000 options to buy @ $3.24, valued at $9.7k
01/27/2021 4/A Shenouda Maged (CFO) has filed a Form 4 on RELMADA THERAPEUTICS, INC.
Txns: Exercised 4,000 shares @ $3.24, valued at $13k
01/26/2021 4 Shenouda Maged (CFO) has filed a Form 4 on RELMADA THERAPEUTICS, INC.
Txns: Exercised 4,000 shares @ $324, valued at $1.3M
Sold 1,704 shares @ $35.41, valued at $60.3k
Sold 409 shares @ $36.15, valued at $14.8k
Sold 1,280 shares @ $35.27, valued at $45.1k
Sold 607 shares @ $35.16, valued at $21.3k
Exercised 4,000 options to buy @ $3.24, valued at $13k
01/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/23/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/21/2019 4 Shenouda Maged (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.
Txns: Bought 978 shares @ $23, valued at $22.5k
07/30/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/02/2019 4 Shenouda Maged (CFO) has filed a Form 4 on AzurRx BioPharma, Inc.
Txns: Bought 20,000 shares @ $1.3107, valued at $26.2k
12/20/2018 4 Shenouda Maged (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.
Txns: Granted 450,000 options to buy @ $1.15, valued at $517.5k
07/16/2018 4 Shenouda Maged (CFO) has filed a Form 4 on AzurRx BioPharma, Inc.
Txns: Granted 100,000 options @ $3.04, valued at $304k
10/23/2017 4 Shenouda Maged (CFO) has filed a Form 4 on AzurRx BioPharma, Inc.
Txns: Granted 22,500 shares @ $0
10/23/2017 4 Shenouda Maged (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.
Txns: Granted 425,000 options to buy @ $0.81, valued at $344.3k
09/27/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/07/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
10/11/2016 3 Shenouda Maged (Director) has filed a Form 3 on AzurRx BioPharma, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy